Safety and efficacy of venom immunotherapy: a real life study
Introduction: Venom immunotherapy (VIT) is recommended as the first-line treatment for patients allergic to Hymenoptera venom. Aim: To analyze the safety and efficacy of VIT in a real life setting. Material and methods: One hundred and eighty patients undergoing VIT were studied to evaluate...
Main Authors: | Agnieszka Kołaczek, Dawid Skorupa, Monika Antczak-Marczak, Piotr Kuna, Maciej Kupczyk |
---|---|
Format: | Article |
Language: | English |
Published: |
Termedia Publishing House
2017-04-01
|
Series: | Advances in Dermatology and Allergology |
Subjects: | |
Online Access: | https://www.termedia.pl/Safety-and-efficacy-of-venom-immunotherapy-a-real-life-study,7,29795,1,1.html |
Similar Items
-
Venom Immunotherapy: From Proteins to Product to Patient Protection
by: Martin Feindor, et al.
Published: (2021-09-01) -
Hymenoptera venom allergy and immunotherapy - what a General Practitioner should know
by: Zuzanna Mazurkiewicz, et al.
Published: (2021-04-01) -
Safety and tolerability of venom immunotherapy: Evaluation of 581 rush- and ultra-rush induction protocols (safety of rush and ultra-rush venom immunotherapy)
by: Richard Stock, et al.
Published: (2021-01-01) -
Risk factors for severe systemic sting reactions in wasp (Vespula spp.) and honeybee (Apis mellifera) venom allergic patients
by: Danielle Fehr, et al.
Published: (2019-10-01) -
SAFETY OF VENOMENHAL® VENOM IN MAINTENANCE HYMENOPTERA VENOM IMMUNOTHERAPY
by: Mitja Košnik, et al.
Published: (2001-10-01)